Vimarsana
Biggest News Aggregation in the World

Page 5 - Multiple Ascending Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Ascending Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Ascending Dose Today - Breaking & Trending Today

Sun Pharma Presents Data from First-in-Human Phase 1 Studies of GL0034 at the American Diabetes Association 83rd Scientific Sessions - Vimarsana News

Sun Pharma Presents Data from First-in-Human Phase 1 Studies of GL0034 at the American Diabetes Association 83rd Scientific Sessions

/PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" including its subsidiaries...

Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates - Vimarsana News

Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates - Vimarsana News

Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates - Vimarsana News

Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates

Enrollment progressing in Phase 1b Multiple-Ascending Dose (MAD) study of RGLS8429 in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Top-line data in the first cohort of RGLS8429-treated ADPKD patients anticipated in second half of ...

Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates - Vimarsana News

Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...